Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis (Q72318354)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

P Salvati

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

E Lamberti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

R Ferrario

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

R G Ferrario

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

G Scampini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

F Pugliese

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

P Barsotti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

C Patrono

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

language of work or name

English

0 references

publication date

1 April 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

1168-1175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

25 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

NIH conference. Lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Enhanced renal leukotriene production in murine lupus: Role of lipoxygenase metabolites

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Successful treatment of lupus nephritis in MRL-lpr/lpr mice by inhibiting ornithine decarboxylase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Increased renal thromboxane production in murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Physiological role for enhanced renal thromboxane production in murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Thromboxane synthesis and action within the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Improvement of renal function with selective thromboxane antagonism in lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Thromboxane receptor blockade reduces renal injury in murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

CYCLOPHOSPHAMIDE TREATMENT OF RENAL DISEASE IN (NZB × NZW) F1 HYBRID MICE

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

The immunopathology of SLE

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Introduction to sample size determination and power analysis for clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Estimating survival functions from the life table

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Effect of eicosapentaenoic acid rich menhaden oil and MaxEPA on the autoimmune disease of Mrl/l mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Measurement of renal and non-renal eicosanoid synthesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.166

7 January 2021

Identifiers

DOI

10.1038/KI.1995.166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783415%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference